Aperam recovers 1.2% to 26.25 euros this Friday, while AlphaValue accumulates the file, but with a target price adjusted down from 33.50 to 29 euros. BNP Paribas Exane remains at ‘outperformance’ on the value, with a target of 31.50 euros, in the wake of the last publication…
©2024 Boursier.com